ProStrakan rebrands as Kyowa Kirin International PLC
Kyowa Hakko Kirin (KHK), the company that acquired ProStraken in 2011, has decided that its western pharmaceutical subsidiaries are to adopt the Kyowa Kirin name...
List view / Grid view
Kyowa Hakko Kirin (KHK), the company that acquired ProStraken in 2011, has decided that its western pharmaceutical subsidiaries are to adopt the Kyowa Kirin name...
1 March 2016 | By Victoria White
ProStrakan will make an upfront payment to AstraZeneca of $70 million to acquire the rights to Moventig in the EU, Iceland, Norway, Switzerland and Liechtenstein...